NUP49 Antibody

What is NUP49 and why is it important in cellular research?

NUP49 is a nuclear pore complex (NPC) protein that belongs to a novel family of yeast nucleoporins. It is essential for cell viability and plays a critical role in mediating bidirectional nucleocytoplasmic transport . The amino-terminal region of NUP49 contains repeated "GLFG" motifs separated by glutamine, asparagine, serine, and threonine-rich spacers, which are characteristic structural features of this nucleoporin family . As a component of the nuclear pore complex, NUP49 is fundamentally important for understanding cellular compartmentalization, gene expression regulation, and nuclear transport mechanisms that are essential to cellular function.

What applications are NUP49 antibodies commonly used for?

NUP49 antibodies are utilized across multiple experimental applications in molecular and cellular biology. The most common applications include Western Blot (WB), immunohistochemistry (IHC), immunoprecipitation (IP), immunocytochemistry (ICC), and immunofluorescence (IF) . These techniques allow researchers to detect, localize, and quantify NUP49 protein in various biological samples. Electron microscopy applications have been particularly valuable for precisely localizing NUP49 within the nuclear pore complex structure at high resolution . Flow cytometry applications may also be employed when analyzing cell populations for nuclear envelope integrity or during studies of cell cycle regulation.

How should I design experiments to validate NUP49 antibody specificity?

Validating NUP49 antibody specificity requires a multi-approach strategy. First, perform Western blot analysis with positive and negative control samples to confirm the antibody recognizes a protein of the expected molecular weight (approximately 49 kDa for yeast NUP49) . Second, conduct immunoprecipitation followed by mass spectrometry to confirm the identity of the precipitated protein. Third, use genetic approaches with NUP49 knockout or knockdown models, if available, to confirm the signal disappears or diminishes in the absence of the target. Fourth, employ epitope-tagged versions of NUP49 (as described in research using the HA epitope tag) and confirm co-localization of signals from the anti-NUP49 antibody and an antibody against the tag . Finally, cross-validate results using alternative antibodies targeting different epitopes of NUP49 to ensure consistent localization patterns.

What are the optimal fixation and permeabilization methods for NUP49 immunofluorescence studies?

For optimal immunofluorescence detection of NUP49, a balanced approach to fixation and permeabilization is critical. Based on protocols used in nuclear pore complex studies, the following method is recommended: Fix cells with 2-4% paraformaldehyde for 15-20 minutes at room temperature to preserve structural integrity while maintaining antigenicity . For permeabilization, use 0.1-0.5% Triton X-100 for 5-10 minutes, which effectively permeabilizes the nuclear envelope while preserving nuclear pore complex structure . Alternatively, a gentler methanol fixation/permeabilization (-20°C for 10 minutes) may be used for some antibodies. When working with yeast cells, which have cell walls, additional considerations include enzymatic digestion with zymolyase or lyticase prior to fixation. Always optimize these conditions for your specific cell type and antibody, as overfixation can mask epitopes while insufficient fixation may compromise structural preservation.

What controls should be included in NUP49 antibody experiments?

A comprehensive control strategy for NUP49 antibody experiments should include:

• Primary antibody omission control: Process samples without the primary NUP49 antibody to identify non-specific binding of secondary antibodies

• Isotype control: Use an irrelevant antibody of the same isotype and concentration to identify non-specific binding

• Absorption control: Pre-incubate the NUP49 antibody with excess purified NUP49 protein to demonstrate specificity

• Genetic controls: When possible, include NUP49 knockout/knockdown samples as negative controls

• Cross-validation control: Compare results with alternative antibodies targeting different NUP49 epitopes

• Epitope tag controls: For tagged constructs, compare staining patterns between the NUP49 antibody and an antibody against the epitope tag

• Subcellular marker controls: Co-stain with established markers of the nuclear envelope (like lamin proteins) to confirm proper localization

How can I utilize NUP49 antibodies for live-cell imaging studies?

For live-cell imaging of NUP49, traditional antibodies are generally not suitable as they cannot penetrate intact cells. Instead, consider these approaches:

• Fluorescently-tagged NUP49 fusion proteins: Generate expression constructs encoding NUP49 fused to fluorescent proteins (e.g., GFP, mCherry). Verify that the fusion protein localizes correctly and functions normally through complementation studies .

• Nanobody-based detection: If available, use anti-NUP49 nanobodies (single-domain antibody fragments) conjugated to cell-permeable peptides and fluorophores.

• SNAP/CLIP-tag technology: Create NUP49 fusion constructs with SNAP or CLIP tags that can be labeled with membrane-permeable fluorescent substrates.

• Verification methods: Compare the dynamics observed in live-cell imaging with fixed-cell studies using conventional antibodies to ensure the fusion protein accurately represents endogenous NUP49 behavior.

• Physiological considerations: Maintain optimal imaging conditions (temperature, CO2, pH) to prevent artifacts in nuclear pore complex dynamics, and minimize exposure times and laser power to reduce phototoxicity.

What approaches can be used to study NUP49 interactions with other nuclear pore complex proteins?

Multiple complementary approaches can be employed to study NUP49 interactions:

• Co-immunoprecipitation (Co-IP): Use anti-NUP49 antibodies to pull down NUP49 and its interacting partners, followed by Western blot or mass spectrometry analysis. For enhanced specificity, epitope-tagged versions of NUP49 can be utilized as described in the literature .

• Proximity labeling: Techniques such as BioID or APEX2, where NUP49 is fused to a biotin ligase or peroxidase, can identify neighboring proteins in the native cellular environment.

• Fluorescence resonance energy transfer (FRET): Tag NUP49 and potential interacting partners with appropriate fluorophore pairs to detect direct protein-protein interactions in cells.

• Yeast two-hybrid screening: Although this approach occurs outside the nuclear pore context, it can identify direct binding partners of specific NUP49 domains.

• Cross-linking mass spectrometry (XL-MS): This technique captures transient and stable interactions by chemically cross-linking proteins in close proximity before mass spectrometry analysis.

• Cryo-electron microscopy: For structural studies of NUP49 within the nuclear pore complex, cryo-EM combined with immunogold labeling using NUP49 antibodies can reveal the spatial organization of interactions .

How can I apply super-resolution microscopy with NUP49 antibodies to study nuclear pore complex architecture?

Super-resolution microscopy paired with NUP49 antibodies can reveal unprecedented details of nuclear pore complex architecture:

• Sample preparation optimization: Use thin sections (≤100 nm) for 3D-SIM or STED microscopy and consider specialized fixation protocols that preserve nanoscale structure while maintaining antibody epitope accessibility .

• Antibody selection and validation: Choose high-affinity antibodies with minimal background and validate localization patterns compared to electron microscopy data .

• Multi-color imaging strategy: Co-label NUP49 with antibodies against other nucleoporins to map relative positions within the pore complex. Consider using directly conjugated primary antibodies to minimize the displacement error introduced by secondary antibodies.

• Quantitative analysis: Employ specialized software to measure distances between NUP49 and other nucleoporins, determine the stoichiometry of components, or assess structural changes under different conditions.

• Technical approaches:

  • STORM/PALM: Achieve 10-20 nm resolution using photoswitchable fluorophores

  • STED microscopy: Obtain 30-70 nm resolution with specialized depletion lasers

  • Expansion microscopy: Physically expand samples to resolve structures below the diffraction limit

• Validation with correlative techniques: Compare super-resolution data with electron microscopy to validate findings and provide complementary structural information .

What are the common causes of non-specific binding with NUP49 antibodies and how can they be resolved?

Non-specific binding with NUP49 antibodies can arise from several factors:

• Cross-reactivity with related nucleoporins: NUP49 belongs to a family of nucleoporins sharing similar GLFG repeat domains . To mitigate this:

  • Use antibodies raised against unique regions of NUP49 rather than the repeat domains

  • Increase washing stringency with higher salt concentrations or mild detergents

  • Pre-absorb antibodies with recombinant proteins containing similar repeat domains

• Fixation artifacts: Overfixation can create artificial epitopes while underfixation may alter nuclear pore complex structure. Optimize fixation by:

  • Testing different fixative concentrations and durations

  • Comparing different fixatives (paraformaldehyde vs. methanol)

  • Using epitope retrieval methods if appropriate

• Antibody concentration issues: Titrate primary and secondary antibodies to find optimal concentrations that maximize specific signal while minimizing background.

• Blocking efficiency: Enhance blocking by:

  • Using a combination of BSA, serum, and non-fat dry milk

  • Extending blocking time (overnight at 4°C)

  • Adding 0.1-0.3% Triton X-100 to blocking solutions to reduce hydrophobic interactions

• Detection system sensitivity: If using HRP-conjugated secondary antibodies, switch to more sensitive detection methods like tyramide signal amplification for weak signals, or reduce sensitivity for overly strong non-specific signals.

How should I interpret contradictory results between different detection methods when studying NUP49?

When faced with contradictory results between different detection methods:

• Evaluate epitope accessibility: Different techniques expose different epitopes. For example, Western blotting detects denatured epitopes while immunofluorescence relies on native conformation. The GLFG repeat domains of NUP49 might present differently across methods .

• Consider protein modifications: Post-translational modifications of NUP49 may affect antibody recognition in a method-dependent manner. Phosphorylation states, in particular, may vary as NUP49 has been identified as a mitotic phosphoprotein (also known as MP44) .

• Assess cellular compartmentalization: NUP49 may show different localization patterns depending on cell cycle stage or physiological conditions. Nuclear envelope breakdown during mitosis redistributes nuclear pore complex proteins .

• Perform method-specific controls: For example, if Western blot shows a signal but immunofluorescence does not:

  • Confirm sample preparation preserves the epitope

  • Test alternative fixation and permeabilization methods

  • Use epitope-tagged versions of NUP49 to validate antibody accessibility

• Consider species-specific differences: If working across species, sequence divergence might affect antibody recognition. Yeast NUP49 shares structural features but might have sequence differences from mammalian homologs .

• Employ a third, independent method: Use mass spectrometry, electron microscopy, or proximity labeling as tie-breakers when results conflict .

What are the best practices for quantifying NUP49 expression levels in different experimental conditions?

Quantifying NUP49 expression requires rigorous methodology:

• Western blot quantification:

  • Use a standard curve with recombinant NUP49 protein

  • Normalize to multiple housekeeping proteins (not just one)

  • Employ fluorescent secondary antibodies for wider linear detection range

  • Use biological triplicates and technical replicates

• Immunofluorescence quantification:

  • Standardize image acquisition parameters (exposure, gain, offset)

  • Measure nuclear rim fluorescence intensity using line scans perpendicular to the nuclear envelope

  • Calculate nuclear pore density by counting discrete NUP49 puncta per unit area

  • Compare signal-to-background ratios rather than absolute intensities

• Flow cytometry:

  • Establish proper gating strategies based on controls

  • Use median fluorescence intensity rather than mean

  • Account for cell cycle stage when interpreting results

• RT-qPCR for transcript levels:

  • Design primers specific to NUP49 mRNA

  • Use multiple reference genes for normalization

  • Correlate transcript data with protein levels from other methods

• Data reporting standards:

  • Present both raw and normalized data

  • Clearly state normalization methods

  • Report biological and technical replicate numbers

  • Use appropriate statistical tests based on data distribution

How can I distinguish between different isoforms or modified forms of NUP49 in my experiments?

Distinguishing between different forms of NUP49 requires specialized approaches:

• Isoform-specific detection:

  • Use antibodies targeting unique regions in specific isoforms

  • Employ RT-PCR with isoform-specific primers to correlate protein with mRNA expression

  • Consider that the human version of NUP49 (NUP35) has three identified isoforms with a canonical form of 326 amino acids

• Post-translational modification analysis:

  • Use phospho-specific antibodies when available

  • Perform Western blots before and after phosphatase treatment

  • Employ 2D gel electrophoresis to separate different phosphorylated states

  • Consider mass spectrometry to identify specific modification sites

• Gel mobility analysis:

  • Use Phos-tag acrylamide gels to separate phosphorylated forms

  • Employ gradient gels for better resolution of different molecular weight forms

  • Perform Western blots with samples collected at different cell cycle stages to detect cell cycle-dependent modifications

• Immunoprecipitation strategies:

  • Sequential immunoprecipitation with different antibodies

  • Immunoprecipitate with anti-NUP49 antibodies followed by blotting with modification-specific antibodies (anti-phospho, anti-SUMO, etc.)

• Mass spectrometry characterization:

  • Submit immunoprecipitated NUP49 for LC-MS/MS analysis

  • Use targeted proteomics approaches to quantify specific modifications

  • Compare modification profiles under different experimental conditions

How does NUP49 antibody staining compare with other nuclear pore complex protein markers?

NUP49 antibody staining shows distinctive patterns when compared to other nuclear pore complex markers:

Key comparative findings:

• NUP49 antibodies show more concentrated nuclear rim staining with less nucleoplasmic signal compared to certain other nucleoporins

• NUP49 antibody specificity is generally higher due to its essential nature and distinctive domains

• Co-localization studies confirm NUP49 resides in the same structures as other nucleoporins but precise positioning within the NPC may differ

• The antibody specificity profile can be used to distinguish between the GLFG family members and other nucleoporin families

What are the key considerations when adapting NUP49 antibody protocols across different model organisms?

Adapting NUP49 antibody protocols across model organisms requires careful consideration:

• Sequence homology assessment:

  • Verify epitope conservation between species using sequence alignment tools

  • Consider that while the structure and function of nuclear pore complexes are conserved, sequence divergence may affect antibody recognition

  • Yeast NUP49 may have structural but not sequence homology with mammalian counterparts like NUP35

• Species-specific protocol modifications:

  • Yeast: Requires cell wall digestion with enzymes like zymolyase before fixation

  • Mammalian cells: Standard protocols with Triton X-100 permeabilization are usually effective

  • Drosophila/C. elegans: May require longer fixation times and specialized permeabilization

• Validation strategies across species:

  • Confirm antibody specificity in each new species with Western blots

  • Use heterologous expression of the target organism's NUP49 in a well-characterized system

  • Consider developing epitope-tagged versions in the new model organism

• Technical adaptations:

  • Adjust fixation conditions based on the specific model organism's cellular architecture

  • Modify blocking buffers to account for different sources of background

  • Adjust antibody concentrations and incubation times based on tissue complexity

• Alternative approaches when direct antibody use fails:

  • Use epitope tagging strategies with conserved tag antibodies

  • Consider using orthologous antibodies raised against the model organism's version of NUP49

  • Develop new antibodies against species-specific sequences

How can I use NUP49 antibodies in combination with emerging spatial transcriptomics techniques?

Integrating NUP49 antibodies with spatial transcriptomics offers powerful insights into nuclear organization and gene expression:

• Sequential immunofluorescence and RNA-FISH:

  • First perform NUP49 immunostaining to map nuclear pore complex distribution

  • Follow with RNA-FISH to localize specific transcripts

  • Analyze spatial relationships between active genes and nuclear pore proximity

• Proximity labeling approaches:

  • Fuse biotin ligase (BioID) or peroxidase (APEX) to NUP49

  • After activation, biotinylated RNAs and proteins can be captured

  • Analyze RNA species associated with nuclear pore complexes through sequencing

• In situ sequencing with immunodetection:

  • Combine NUP49 antibody staining with methods like MERFISH or seqFISH

  • Correlate transcript localization patterns with nuclear pore complex distribution

  • Identify genes preferentially expressed at or near nuclear pores

• Technical considerations:

  • Optimize fixation conditions to preserve both protein epitopes and RNA integrity

  • Consider signal amplification methods for detecting low-abundance transcripts

  • Develop computational pipelines to correlate spatial protein and RNA data

• Biological applications:

  • Investigate gene gating hypotheses (the anchoring of active genes to nuclear pores)

  • Study mRNA export pathways with single-molecule resolution

  • Analyze changes in spatial organization during cellular differentiation or stress responses

What are the most recent advances in using NUP49 antibodies for studying nuclear pore complex dynamics during cell cycle progression?

Recent advances in studying nuclear pore complex dynamics with NUP49 antibodies include:

• Live cell imaging approaches:

  • Development of cell-permeable fluorescently labeled Fab fragments against NUP49

  • Use of split-GFP systems where one fragment is fused to NUP49

  • Correlative live-fixed cell imaging to track dynamics then confirm with high-resolution antibody staining

• Super-resolution time-lapse microscopy:

  • Implementation of lattice light-sheet microscopy with adaptive optics

  • Development of MINFLUX nanoscopy for tracking individual nuclear pore complexes

  • 4D super-resolution imaging (3D + time) of NUP49 during mitosis

• Cell cycle-specific investigations:

  • Synchronized cell populations analyzed at defined timepoints

  • Combination of NUP49 antibodies with cell cycle markers

  • Quantitative analysis of NUP49 phosphorylation states throughout mitosis

• Methodological innovations:

  • Development of optogenetic tools to acutely disrupt NUP49 function

  • CRISPR-based endogenous tagging for physiological expression level imaging

  • Mass spectrometry workflow to identify cell cycle-dependent interaction partners

• Key biological findings:

  • Characterization of nuclear pore complex disassembly/reassembly kinetics

  • Identification of NUP49 post-translational modifications during mitotic progression

  • Elucidation of the role of NUP49 in nuclear envelope breakdown and reformation

By incorporating these advanced techniques, researchers can gain unprecedented insights into the dynamic behavior and functional significance of NUP49 within the nuclear pore complex across diverse cellular contexts.